| Dermatology in the Primary Care Office In-person Event | eMedEvents |
| https://www.emedevents.com/c/medical-conferences-2023/dermatology-in-the-primary-care-office-from-principles-to-practice-strategies-in-person-event |
| Dermatology in the Primary Care Office – From Principles to Practice Strategies is organized by American Medical Seminars (AMS), Inc. and will be held from Dec 11 - 14, 2023, Sarasota, Florida, USA |
| read more |
|
|
| eMed News - Daily Medical News & Articles Updates on eMedEvents |
| https://rb.gy/y2ubj4 |
| Medical news and health news headlines posted throughout the day, You can trust from around the world. All content is written and reviewed by qualified health, medical and scientific experts. |
| read more |
|
|
| Regenerative Medicine Market to Grow at a CAGR of 27.2% During the Forecast 2027 |
| https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579 |
| The global regenerative medicine market in terms of revenue was estimated to be worth $12.2 Billion in 2022 and is poised to reach $40.6 Billion by 2027, growing at a CAGR of 27.2% from 2022 to 2027. The new research study consists of an industry tre |
| read more |
|
|
| Parafoveal Telangiectasia Ayurvedic Treatment in India Sanjeevan Netralaya |
| https://www.sanjeevannetralaya.com/parafoveal-telangiectasia-pft/ |
| Parafoveal telangiectasia, also known as idiopathic juxtafoveal telangiectasia type 2 or Macular Telangiectasia Type 2, is an uncommon eye disease that affects the blood vessels of the macula–the central part responsible for sharp, detailed visionâ |
| read more |
|
|
| 9th Digital Pathology & AI Congress: USA | eMedEvents |
| https://www.emedevents.com/c/medical-conferences-2023/9th-digital-pathology-ai-congress-usa |
| Digital Pathology & AI 9th Annual Congress 2023 is organized by Global Engage Ltd and will be held from Jun 22 - 23, in New York, USA |
| read more |
|
|
| Exploring the Latest Technological Advancements in Therapeutic Drug Monitoring |
| https://www.prnewswire.com/news-releases/therapeutic-drug-monitoring-market-worth-2-9-billion-by-2027---exclusive-report-by-marketsandmarkets-301736128.htm |
| The global therapeutic drug monitoring market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 9.6% from 2022 to 2027. The growth of this market is primarily driven b |
| read more |
|
|
